Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OVOL3 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | NADK | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
mRNA | MFRP | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
mRNA | KCTD19 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | GBF1 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
mRNA | POLR1C | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
mRNA | MAP2K2 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
mRNA | NEDD4 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
mRNA | NUDT21 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
mRNA | CSPG4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |